A Study of Full Treatment-free Remission in Patients With Chronic Myeloid Leukemia

Clinical trial NCT03874858 · TERMINATED

Trial details

NCT number: NCT03874858
Sponsor: Novartis Pharmaceuticals
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Myeloid Leukemia

Start date: 2019-03-22
Primary completion: 2025-10-15
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.